What’s ahead for BRCA genetic testing and counseling?

| | March 10, 2014
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

The US Supreme Court’s landmark decision last June, mandating that an individual’s genes cannot be patented, transformed the genetic testing landscape and opened the marketplace to a host of new and complicated testing options.

That decision—alongside actress Angelina Jolie’s highly publicized choice to undergo a prophylactic double mastectomy due to her family history and her own BRCA mutation status—have shined a spotlight on hereditary cancer risk, presenting both opportunities and challenges for today’s oncology practitioner.

Read the full, original story: What’s Ahead for BRCA Genetic Testing and Counseling? 

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend